Related Experiment Video
Updated: Jul 20, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis
M N Merrett1, N Mortensen, M Kettlewell
1Gastroenterology Unit, Radcliffe Infirmary, Oxford.
Current smokers experience significantly fewer pouchitis episodes after ileal pouch-anal anastomosis compared to non-smokers and ex-smokers. This suggests smoking may offer a protective effect against pouchitis in ulcerative colitis patients.
Area of Science:
- Gastroenterology
- Clinical Epidemiology
Background:
- Ulcerative colitis (UC) patients have an elevated risk of pouchitis post-ileal pouch-anal anastomosis (IPAA).
- Epidemiological data indicate a higher UC risk in non-smokers and recent ex-smokers.
Purpose of the Study:
- To investigate the association between smoking habits and the incidence of pouchitis in UC patients undergoing IPAA.
- To determine if smoking status influences pouchitis development or frequency.
Main Methods:
- Retrospective analysis of UC patients with functioning pouches (≥12 months).
- Smoking status categorized as smoker, ex-smoker (<7 years cessation), and non-smoker (>7 years cessation).
- Pouchitis defined by increased stool frequency and acute inflammation on biopsy; episodes were counted.
Main Results:
- Smokers (n=17) experienced significantly fewer pouchitis episodes (1 episode) compared to non-smokers (n=72, 46 episodes; p=0.0005) and ex-smokers (n=12, 14 episodes; p=0.05).
- No significant association was found between smoking habit and other adverse outcomes like hemorrhage, sepsis, or pouch excision.
Conclusions:
- Smoking appears to be associated with a reduced incidence of pouchitis in ulcerative colitis patients following IPAA.
- Further research is warranted to elucidate the mechanisms behind this protective effect and its clinical implications.
More Related Videos
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

